Gary Box

4.4k total citations
36 papers, 1.2k citations indexed

About

Gary Box is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Gary Box has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 10 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Gary Box's work include Cancer-related Molecular Pathways (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Gary Box is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), Nanoplatforms for cancer theranostics (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Gary Box collaborates with scholars based in United Kingdom, United States and Switzerland. Gary Box's co-authors include Suzanne A. Eccles, William Court, Pornchai O‐charoenrat, Peter Rhŷs‐Evans, Simon P. Robinson, Melanie Valenti, Helmout Modjtahedi, Alexis de Haven Brandon, Florence I. Raynaud and Jessica K.R. Boult and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Cell Biology and Molecular and Cellular Biology.

In The Last Decade

Gary Box

34 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary Box United Kingdom	19	646	421	241	190	181	36	1.2k
Jun Nakayama Japan	19	752 1.2×	250 0.6×	178 0.7×	151 0.8×	88 0.5×	51	1.1k
Jason J. Christiansen United States	7	612 0.9×	585 1.4×	271 1.1×	117 0.6×	220 1.2×	8	1.2k
Helen Kalirai United Kingdom	25	847 1.3×	613 1.5×	221 0.9×	256 1.3×	128 0.7×	89	1.8k
Viia Valge-Archer United Kingdom	19	1.1k 1.7×	1.0k 2.4×	373 1.5×	238 1.3×	82 0.5×	27	2.4k
Christopher J. Tape United Kingdom	20	548 0.8×	637 1.5×	235 1.0×	133 0.7×	174 1.0×	36	1.3k
Yongping Crawford United States	14	1.1k 1.7×	581 1.4×	450 1.9×	89 0.5×	100 0.6×	16	1.5k
Isaiah J. Fidler United States	16	816 1.3×	750 1.8×	476 2.0×	131 0.7×	138 0.8×	20	1.7k
Yaron Mosesson Israel	10	1.1k 1.7×	453 1.1×	133 0.6×	153 0.8×	463 2.6×	15	1.5k
Janna Paulsson Sweden	19	748 1.2×	703 1.7×	398 1.7×	102 0.5×	99 0.5×	21	1.5k
Brian R. Stoll United States	10	542 0.8×	398 0.9×	292 1.2×	130 0.7×	156 0.9×	11	1.1k

Countries citing papers authored by Gary Box

Since Specialization

Citations

This map shows the geographic impact of Gary Box's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Box with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Box more than expected).

Fields of papers citing papers by Gary Box

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary Box. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Box. The network helps show where Gary Box may publish in the future.

Co-authorship network of co-authors of Gary Box

This figure shows the co-authorship network connecting the top 25 collaborators of Gary Box. A scholar is included among the top collaborators of Gary Box based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Box. Gary Box is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burmi, Rajpal S., Gary Box, Umar Wazir, et al.. (2022). Breast Tumour Kinase (Brk/PTK6) Contributes to Breast Tumour Xenograft Growth and Modulates Chemotherapeutic Responses In Vitro. Genes. 13(3). 402–402. 4 indexed citations

Moore, Andrew S., Amir Faisal, Grace Wing-Yan Mak, et al.. (2020). Quizartinib-resistant FLT3-ITD acute myeloid leukemia cells are sensitive to the FLT3-Aurora kinase inhibitor CCT241736. Blood Advances. 4(7). 1478–1491. 20 indexed citations

Brandon, Alexis de Haven, Gary Box, Albert Hallsworth, et al.. (2020). Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice. Scientific Reports. 10(1). 10799–10799. 17 indexed citations

Bush, Nigel, Andrew Healey, Anant Shah, et al.. (2019). Therapeutic Dose Response of Acoustic Cluster Therapy in Combination With Irinotecan for the Treatment of Human Colon Cancer in Mice. Frontiers in Pharmacology. 10. 1299–1299. 12 indexed citations

Wagner, Steve, Alexis de Haven Brandon, Melanie Valenti, et al.. (2018). Abstract LB-094: Suppression of inflammatory gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer. Cancer Research. 78(13_Supplement). LB–94. 1 indexed citations

Ang, Joo Ern, Ákos Pál, Yasmin J. Asad, et al.. (2017). Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma. Molecular Cancer Therapeutics. 16(10). 2315–2323. 8 indexed citations

Boult, Jessica K.R., Gary Box, Maria Vinci, et al.. (2017). Evaluation of the Response of Intracranial Xenografts to VEGF Signaling Inhibition Using Multiparametric MRI. Neoplasia. 19(9). 684–694. 16 indexed citations

Shah, Anant, Nigel Bush, Gary Box, Suzanne A. Eccles, & Jeffrey C. Bamber. (2017). Value of combining dynamic contrast enhanced ultrasound and optoacoustic tomography for hypoxia imaging. Photoacoustics. 8. 15–27. 13 indexed citations

Ang, Joo Ern, Yasmin J. Asad, Alan T. Henley, et al.. (2016). Plasma Metabolomic Changes following PI3K Inhibition as Pharmacodynamic Biomarkers: Preclinical Discovery to Phase I Trial Evaluation. Molecular Cancer Therapeutics. 15(6). 1412–1424. 16 indexed citations

10.

Boult, Jessica K.R., Alexa Jury, Sergey Popov, et al.. (2016). Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd‐DTPA and USPIO‐enhanced imaging. NMR in Biomedicine. 29(11). 1608–1617. 11 indexed citations

11.

Jamin, Yann, Jessica K.R. Boult, Jin Li, et al.. (2015). Exploring the Biomechanical Properties of Brain Malignancies and Their Pathologic Determinants In Vivo with Magnetic Resonance Elastography. Cancer Research. 75(7). 1216–1224. 89 indexed citations

12.

Box, Gary, Nina Tunariu, Mateus Crespo, et al.. (2014). Preclinical Evaluation of Imaging Biomarkers for Prostate Cancer Bone Metastasis and Response to Cabozantinib. JNCI Journal of the National Cancer Institute. 106(4). dju033–dju033. 51 indexed citations

13.

Box, Carol, Marta Mendiola, Sharon Gowan, et al.. (2013). A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma. European Journal of Cancer. 49(11). 2512–2521. 11 indexed citations

14.

Walton, Mike I., Paul D. Eve, Angela Hayes, et al.. (2012). CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs. Clinical Cancer Research. 18(20). 5650–5661. 69 indexed citations

15.

Bielen, Aleksandra, Lara Perryman, Gary Box, et al.. (2011). Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β. Molecular Cancer Therapeutics. 10(8). 1407–1418. 41 indexed citations

16.

Walker‐Samuel, Simon, et al.. (2011). Non‐invasive in vivo imaging of vessel calibre in orthotopic prostate tumour xenografts. International Journal of Cancer. 130(6). 1284–1293. 17 indexed citations

17.

Box, Gary & Suzanne A. Eccles. (2011). Simple Experimental and Spontaneous Metastasis Assays in Mice. Methods in molecular biology. 769. 311–329. 10 indexed citations

18.

Walton, Michael I., Paul D. Eve, Angela Hayes, et al.. (2010). The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106. Molecular Cancer Therapeutics. 9(1). 89–100. 63 indexed citations

19.

Modjtahedi, Helmout, David K. Moscatello, Gary Box, et al.. (2003). Targeting of cells expressing wild‐type EGFR and type‐III mutant EGFR (EGFRvIII) by anti‐EGFR MAb ICR62: A two‐pronged attack for tumour therapy. International Journal of Cancer. 105(2). 273–280. 53 indexed citations

20.

O‐charoenrat, Pornchai, Peter Rhŷs‐Evans, William Court, Gary Box, & Suzanne A. Eccles. (1999). Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands. Clinical & Experimental Metastasis. 17(7). 631–639. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact